AUTHOR INDEX
| |
|
|
|
|
|
Search results for: "S"
Results 171 - 180 of 1023 shown below |
|
| Schechter, Jason B |
|
| Gregory L Gerdeman, Jason B Schechter and Edward D French Context-Specific Reversal of Cocaine Sensitization by the CB1 Cannabinoid Receptor Antagonist Rimonabant doi:10.1038/sj.npp.1301648 Neuropsychopharmacology 33, 2747-2759 | Abstract | Full text | PDF | |
|
| Schechter, Lee E |
|
| Jessica E Malberg, Brian Platt, Stacey J Sukoff Rizzo, Robert H Ring, Irwin Lucki, Lee E Schechter and Sharon Rosenzweig-Lipson Increasing the Levels of Insulin-Like Growth Factor-I by an IGF Binding Protein Inhibitor Produces Anxiolytic and Antidepressant-Like Effects doi:10.1038/sj.npp.1301358 Neuropsychopharmacology 32, 2360-2368 | Abstract | Full text | PDF | |
|
| Lee E Schechter, Qian Lin, Deborah L Smith, Guoming Zhang, Qin Shan, Brian Platt, Michael R Brandt, Lee A Dawson, Derek Cole, Ron Bernotas, Albert Robichaud, Sharon Rosenzweig-Lipson and Chad E Beyer Neuropharmacological Profile of Novel and Selective 5-HT6 Receptor Agonists: WAY-181187 and WAY-208466 doi:10.1038/sj.npp.1301503 Neuropsychopharmacology 33, 1323-1335 | Abstract | Full text | PDF | |
|
| Scheepers, Floortje E |
|
| Floortje E Scheepers, Christine C Gispen de Wied, Hilleke E Hulshoff Pol, Wiesje van de Flier, Jeroen A van der Linden and René S Kahn The Effect of Clozapine on Caudate Nucleus Volume in Schizophrenic Patients Previously Treated with Typical Antipsychotics doi:10.1016/S0893-133X(00)00172-X Neuropsychopharmacology 24, 47-54 | Abstract | Full text | PDF | |
|
| Floortje E Scheepers, Christine C Gispen-de Wied, Herman G M Westenberg and René S Kahn The Effect of Olanzapine Treatment on Monoamine Metabolite Concentrations in the Cerebrospinal Fluid of Schizophrenic Patients doi:10.1016/S0893-133X(01)00250-0 Neuropsychopharmacology 25, 468-475 | Abstract | Full text | PDF | |
|
| Scheggi, Simona |
|
| Flavio Masi, Benedetta Leggio, Giulio Nanni, Simona Scheggi, M Graziella De Montis, Alessandro Tagliamonte, Silvia Grappi and Carla Gambarana Effects of Long-Term Acetyl-L-Carnitine Administration in Rats—II: Protection Against the Disrupting Effect of Stress on the Acquisition of Appetitive Behavior doi:10.1038/sj.npp.1300078 Neuropsychopharmacology 28, 683-693 | Abstract | Full text | PDF | |
|
| Pierluigi Tolu, Flavio Masi, Benedetta Leggio, Simona Scheggi, Alessandro Tagliamonte, M Graziella De Montis and Carla Gambarana Effects of Long-term Acetyl-L-carnitine Administration in Rats: I. Increased Dopamine Output in Mesocorticolimbic Areas and Protection toward Acute Stress Exposure doi:10.1016/S0893-133X(02)00306-8 Neuropsychopharmacology 27, 410-420 | Abstract | Full text | PDF | |
|
| Scheibal, David |
|
| Arthur L Brody, Mark A Mandelkern, Richard E Olmstead, Zoe Allen-Martinez, David Scheibal, Anna L Abrams, Matthew R Costello, Judah Farahi, Sanjaya Saxena, John Monterosso and Edythe D London Ventral Striatal Dopamine Release in Response to Smoking a Regular vs a Denicotinized Cigarette doi:10.1038/npp.2008.87 Neuropsychopharmacology 34, 282-289 | Abstract | Full text | PDF | |
|
| Scheinin, Harry |
|
| Kimmo Ingman, Nora Hagelberg, Sargo Aalto, Kjell Någren, Auni Juhakoski, Sakari Karhuvaara, Antero Kallio, Vesa Oikonen, Jarmo Hietala and Harry Scheinin Prolonged Central -Opioid Receptor Occupancy after Single and Repeated Nalmefene Dosingdoi:10.1038/sj.npp.1300790 Neuropsychopharmacology 30, 2245-2253 | Abstract | Full text | PDF | |
|
| Scheinin, Mika |
|
| Janne Lähdesmäki, Jukka Sallinen, Ewen MacDonald and Mika Scheinin Alpha2A-Adrenoceptors are Important Modulators of the Effects of D-Amphetamine on Startle Reactivity and Brain Monoamines doi:10.1038/sj.npp.1300428 Neuropsychopharmacology 29, 1282-1293 | Abstract | Full text | PDF | |
|
| Scheller, Carsten |
|
| Falko Meisner, Carsten Scheller, Susanne Kneitz, Sieghart Sopper, Eva Neuen-Jacob, Peter Riederer, Volker ter Meulen and Eleni Koutsilieri Memantine Upregulates BDNF and Prevents Dopamine Deficits in SIV-Infected Macaques: A Novel Pharmacological Action of Memantine doi:10.1038/sj.npp.1301615 Neuropsychopharmacology 33, 2228-2236 | Abstract | Full text | PDF | |
|
| Scheltens, Philip |
|
| Rutger Goekoop, Frederik Barkhof, Erik J J Duschek, Coen Netelenbos, Dirk L Knol, Philip Scheltens and Serge ARB Rombouts Raloxifene Treatment Enhances Brain Activation during Recognition of Familiar Items: a Pharmacological fMRI Study in Healthy Elderly Males doi:10.1038/sj.npp.1300956 Neuropsychopharmacology 31, 1508-1518 | Abstract | Full text | PDF | |
|
| Schene, Aart H |
|
| Henricus G Ruhé, Jan Booij, Henk C v Weert, Johannes B Reitsma, Eric J F Fransen, Martin C Michel and Aart H Schene Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial With Assessment of Serotonin Transporter Occupancy doi:10.1038/npp.2008.148 Neuropsychopharmacology 34, 999-1010 | Abstract | Full text | PDF | |
|
| Henricus G Ruhé, Jan Booij, Henk C v Weert, Johannes B Reitsma, Eric JF Fransen, Martin C Michel and Aart H Schene Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial with Assessment of Serotonin Transporter Occupancy doi:10.1038/npp.2008.213 Neuropsychopharmacology 34, 1088-1088 | Abstract | Full text | PDF | |
|
| Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | |
|
| top |
|

-Opioid Receptor Occupancy after Single and Repeated Nalmefene Dosing
